Sirio Pharma Co., Ltd. (300791.SZ)
CNY 28.09
(-0.46%)
CNY 28.09
(-0.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 592.07 Million CNY | 52.97% |
| 2022 | 432.13 Million CNY | 8.36% |
| 2021 | 402.67 Million CNY | 1.69% |
| 2020 | 396.64 Million CNY | 62.71% |
| 2019 | 247.02 Million CNY | -21.81% |
| 2018 | 299.57 Million CNY | 58.89% |
| 2017 | 189.91 Million CNY | -80.13% |
| 2016 | 982.54 Million CNY | 680.66% |
| 2015 | 117.04 Million CNY | 8.52% |
| 2014 | 113.62 Million CNY | 11.74% |
| 2013 | 100.97 Million CNY | 27.42% |
| 2012 | 79.95 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 85.54 Million CNY | -9.59% |
| 2024 Q3 | 101.2 Million CNY | -48.56% |
| 2024 Q2 | 185.36 Million CNY | 41.56% |
| 2023 Q1 | 34.38 Million CNY | -61.24% |
| 2023 FY | - CNY | 52.97% |
| 2023 Q4 | 149.94 Million CNY | 19.19% |
| 2023 Q3 | 125.8 Million CNY | 25.04% |
| 2023 Q2 | 100.61 Million CNY | 192.59% |
| 2022 FY | - CNY | 8.36% |
| 2022 Q4 | 88.71 Million CNY | 12.59% |
| 2022 Q2 | 118.66 Million CNY | 538.55% |
| 2022 Q1 | 18.58 Million CNY | -47.63% |
| 2022 Q3 | 78.78 Million CNY | -33.6% |
| 2021 FY | - CNY | 1.69% |
| 2021 Q1 | 69.05 Million CNY | -28.25% |
| 2021 Q2 | 122.01 Million CNY | 76.69% |
| 2021 Q3 | 72.19 Million CNY | -40.83% |
| 2021 Q4 | 35.48 Million CNY | -50.85% |
| 2020 Q2 | 92.48 Million CNY | 51.69% |
| 2020 Q4 | 96.23 Million CNY | 44.28% |
| 2020 Q1 | 60.96 Million CNY | 188.36% |
| 2020 Q3 | 66.7 Million CNY | -27.87% |
| 2020 FY | - CNY | 62.71% |
| 2019 Q3 | 43.81 Million CNY | -26.8% |
| 2019 FY | - CNY | -21.81% |
| 2019 Q1 | 46.74 Million CNY | -45.26% |
| 2019 Q2 | 59.85 Million CNY | 28.05% |
| 2019 Q4 | 21.14 Million CNY | -51.75% |
| 2018 Q4 | 85.39 Million CNY | 29.68% |
| 2018 Q3 | 65.85 Million CNY | 0.0% |
| 2018 FY | - CNY | 58.89% |
| 2017 FY | - CNY | -80.13% |
| 2016 FY | - CNY | 680.66% |
| 2015 Q4 | 25.75 Million CNY | 0.0% |
| 2015 FY | - CNY | 8.52% |
| 2014 FY | - CNY | 11.74% |
| 2013 FY | - CNY | 27.42% |
| 2012 FY | - CNY | 0.0% |